Trajan Group Holdings Limited (ASX:TRJ)
Australia · Delayed Price · Currency is AUD 0.3800
-0.0150 (-3.80%)
Apr 16, 2026, 3:52 PM AEST
Trajan Group Holdings Market Cap
Trajan Group Holdings has a market cap or net worth of 60.27 million as of April 16, 2026. Its market cap has decreased by -57.00% in one year.
Market Cap
60.27M
Enterprise Value
105.90M
Revenue
169.52M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.38
Market Cap Chart
Since June 7, 2021, Trajan Group Holdings's market cap has decreased from 256.51M to 60.27M, a decrease of -76.50%. That is a compound annual growth rate of -25.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 60.27M | -43.55% |
| Dec 31, 2025 | 106.78M | -37.94% |
| Dec 31, 2024 | 172.05M | -8.48% |
| Dec 29, 2023 | 187.99M | -29.37% |
| Dec 30, 2022 | 266.14M | -49.29% |
| Dec 31, 2021 | 524.85M | 104.61% |
| Jun 7, 2021 | 256.51M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 65.86B |
| Sigma Healthcare | 30.94B |
| Pro Medicus | 13.26B |
| Cochlear | 11.27B |
| PharmX Technologies | 70.89M |
| Mach7 Technologies | 70.50M |
| Cynata Therapeutics | 70.05M |
| Rhythm Biosciences | 63.82M |